Association of triglyceride-glucose index with long-term prognosis in advanced hepatocellular carcinoma patients receiving immunotherapy and targeted therapy

Table 2 Tumor responses of triglyceride-glucose index < 1.58 and triglyceride-glucose index ≥ 1.58, n (%)

Variables	Low TyG index (n = 134)	High TyG index (n = 144)	χ2	P value
CR
0	133 (99.25)	144 (100.00)
1	1 (0.75)	0 (0.00)
PR
0	105 (78.36)	126 (87.50)
1	29 (21.64)	18 (12.50)
SD
0	78 (58.21)	88 (61.11)
1	56 (41.79)	56 (38.89)
PD
0	86 (64.18)	74 (51.39)
1	48 (35.82)	70 (48.61)
ORR			4.75	0.029a
0	104 (77.61)	126 (87.50)
1	30 (22.39)	18 (12.50)
DCR			4.65	0.031a
0	48 (35.82)	70 (48.61)
1	86 (64.18)	74 (51.39)

^aP < 0.05.

TyG: Triglyceride-glucose; CR: Complete response; PR: Partial response; SD: Stable disease; PD: Progression disease; ORR: Objective responds rates; DCR: Disease control rates.